Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment

Glioblastomas (GBM) are deadly brain tumors that currently do not have long-term patient treatments available. GBM overexpress the angiogenesis factor VEGF and its receptor VEGFR2. ETLD1 (epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1), a G-protein coupled r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Nucl Med Mol Imaging
Autori principali: Ziegler, Jadith, Zalles, Michelle, Smith, Nataliya, Saunders, Debra, Lerner, Megan, Fung, Kar-Ming, Patel, Maulin, Wren, Jonathan D, Lupu, Florea, Battiste, James, Towner, Rheal A
Natura: Artigo
Lingua:Inglês
Pubblicazione: e-Century Publishing Corporation 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420708/
https://ncbi.nlm.nih.gov/pubmed/30911439
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi